Skip to main content
Back to RA Capital Management

RA Capital Management's Genetics Portfolio

Browse 4 Genetics companies funded by RA Capital Management. See funding amounts, founder contacts, and investment details.

Genetics Companies
4
Total Funding in Genetics
$396.0M

Genetics Portfolio Companies (4)

Export
BiotechnologyGeneticsHealth CareMedical

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

Charlestown, United States
March 2026
$240.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyGeneticsLife Science

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

New York, United States
August 2025
$44.0M
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyGeneticsHealth DiagnosticsTherapeutics

NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.

Waltham, United States
November 2025
$3.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

GeneticsHealth CareMedical

Sidera Bio harness human genetics, that helps in transformative medicines for patients.

Copenhagen, Denmark
December 2025
$109.0M
Series A

Founder Contacts

19,000+ verified contacts

Explore RA Capital Management's Full Portfolio

View all companies funded by RA Capital Management across every industry and funding stage.

View Full RA Capital Management Portfolio